What Appgate, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ledecky Jonathan J | Director | Oct 25 | Disposition to Issuer · D | −210 | — | — | 9,290,803 |
| Ledecky Jonathan J | Director | Oct 12 | Disposition to Issuer · D | −218,427 | — | — | 9,291,013 |
| Warshaw Kirk M | Chief Financial Officer | Dec 16 | Open-market buy · P | +55,000 | $0.04 | +$2K | 55,000 |
| R R Biotech Partners Llc | 10% owner | Dec 19 | Derivative Conversion · C | +29,630,200 | — | — | 47,547,183 |
| Kling Arnold P | President | Dec 19 | Derivative Conversion · C | +7,407,550 | — | — | 11,886,796 |
Loading...
